Home iVexSol

iVexSol

In operation
Series A
Lentiviral Vector (LVV) Contract Development and Manufacturing Organization (CDMO)

Basic Information

iVexSol is a technology-based lentiviral vector (LVV) contract development and manufacturing organization (CDMO). iVexSol provides intelligent vector solutions for the production of LVV, which are gene delivery vectors and key raw materials for manufacturing life-changing cell and gene therapies (CGT). The technology platform uses vector-producing cell banks to manufacture LVV in larger quantities than current methods and facilitates rapid scalability to meet global demand. These advancements shorten clinical development time and reduce costs.
iVexSol, Inc.
Massachusetts,United States of America
15~50 people
January 01, 2010
(617) 430-4990